BriaCell Therapeutics Corp. — Investor Relations & Filings
BriaCell Therapeutics Corp. is a clinical-stage immuno-oncology company developing a novel class of targeted cellular immunotherapies for cancer. Its lead candidate, Bria-IMT™, is a patented, off-the-shelf, cell-based therapy in a pivotal Phase 3 study for advanced metastatic breast cancer. Bria-IMT™, which has received FDA Fast Track designation, is designed to activate the patient's immune system to kill cancer cells. The company is also advancing its next-generation Bria-OTS™ platform, a personalized off-the-shelf immunotherapy that uses HLA matching to provide treatment for a broad patient population. Clinical studies for the Bria-OTS™ platform are ongoing for breast cancer, with planned expansion into prostate cancer, lung cancer, and melanoma.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - BRIACELL THERAPEUTICS CORP. (0001610820) (Filer) | 2026-02-20 | English | |
| DEF 14A Filing | 2026-02-12 | English | |
| SCHEDULE 13G Filing | 2026-01-23 | English | |
| 8-K | 2026-01-15 | English | |
| 424B4 | 2026-01-14 | English | |
| Regulatory Filings 2026 | 2026-01-14 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 32895080 | 8-K - BRIACELL THERAPEUTICS CORP. (0001610820) (Filer) | 2026-02-20 | English | ||
| 30911158 | DEF 14A Filing | 2026-02-12 | English | ||
| 30911060 | SCHEDULE 13G Filing | 2026-01-23 | English | ||
| 12788475 | 8-K | 2026-01-15 | English | ||
| 12788477 | 424B4 | 2026-01-14 | English | ||
| 12788476 | Regulatory Filings 2026 | 2026-01-14 | English | ||
| 12788480 | S-1MEF | 2026-01-14 | English | ||
| 12788478 | Regulatory Filings 2026 | 2026-01-13 | English | ||
| 12788479 | 8-A12B | 2026-01-13 | English | ||
|
2025
6 filings
| |||||
| 12788481 | 8-K | 2025-12-29 | English | ||
| 12788482 | FWP | 2025-12-23 | English | ||
| 12788483 | S-1 | 2025-12-23 | English | ||
| 12788484 | 10-Q | 2025-12-11 | English | ||
| 12788485 | 8-K | 2025-11-29 | English | ||
| 12788486 | Major Shareholding Notification 2025 | 2025-11-07 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
BriaCell Therapeutics Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34987/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34987 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34987 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34987 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34987}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BriaCell Therapeutics Corp. (id: 34987)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.